Citrulline as a marker for chemotherapy induced mucosal barrier injury in pediatric patients
Pediatric Blood & Cancer2009Vol. 53(7), pp. 1188–1194
Citations Over TimeTop 10% of 2009 papers
Michel J. van Vliet, Wim J. E. Tissing, Edmond H.H.M. Rings, Harma A. Koetse, Frans Stellaard, Willem A. Kamps, Eveline S.J.M. de Bont
Abstract
MBI was reflected by parameters indicating inflammation (IL-8) and cell loss (plasma citrulline, ratio fecal human DNA/total DNA). We conclude that plasma citrulline might be a good parameter for MBI. Further studies are needed to show whether plasma citrulline can be used as a marker for MBI in future research.
Related Papers
- → Fecal Calprotectin(2018)162 cited
- → Fecal calprotectin and α1-antitrypsin dynamics in gastrointestinal GvHD(2015)19 cited
- → Evaluation of fecal calprotectin levels in children aged between 1 and 12 months(2014)1 cited
- → P0925 FECAL CALPROTECTIN: AN INDICATOR OF NEC IN VLBW INFANTS?(2004)
- CALPROTECTIN AND IL-8: MARKERS OF INTESTINAL INFLAMMATION IN (PRE)TERM INFANTS?(2008)